Cost-benefits of new drugs.
Daniel
D G
DG
Moseley
C
C
Rosenfield
S
S
Wolf
S
S
Nawroz
S
S
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000191:economics; D006801:Humans; D018967:Risperidone / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy / Q000191:economics; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D018967:Risperidone